These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31176590)

  • 21. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Radiofrequency Ablation and Hepatic Resection for the Treatment of Hepatocellular Carcinoma 2 cm or Less.
    Huang Y; Shen Q; Bai HX; Wu J; Ma C; Shang Q; Hunt SJ; Karakousis G; Zhang PJ; Zhang Z
    J Vasc Interv Radiol; 2018 Sep; 29(9):1218-1225.e2. PubMed ID: 30075975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis.
    Chang X; Liu T; Zhang F; Ji C; Zhao X; Wang W; Guo H
    J Endourol; 2015 May; 29(5):518-25. PubMed ID: 25556579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer.
    Pecoraro A; Palumbo C; Knipper S; Mistretta FA; Tian Z; Shariat SF; Saad F; Briganti A; Fiori C; Porpiglia F; Karakiewicz PI
    J Urol; 2019 Dec; 202(6):1120-1126. PubMed ID: 31347950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of Percutaneous Thermal Ablation for Biopsy-Proven T1a Renal Cell Carcinoma in Patients With Other Primary Malignancies.
    Abdelsalam ME; Sabir SH; Ba SBK; Karam JA; Matin SF; Wood CG; Ahrar K
    AJR Am J Roentgenol; 2021 Jul; 217(1):157-163. PubMed ID: 33909469
    [No Abstract]   [Full Text] [Related]  

  • 27. Percutaneous Microwave Ablation versus Cryoablation for Small Renal Masses (≤4 cm): 12-Year Experience at a Single Center.
    Sun G; Eisenbrey JR; Smolock AR; Lallas CD; Anton KF; Adamo RD; Shaw CM
    J Vasc Interv Radiol; 2024 Jun; 35(6):865-873. PubMed ID: 38360294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
    Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
    Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SEER study of ablation versus partial nephrectomy in cT1A renal cell carcinoma.
    Zhou M; Mills A; Noda C; Ramaswamy R; Akinwande O
    Future Oncol; 2018 Jul; 14(17):1711-1719. PubMed ID: 29939095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic vs percutaneous cryoablation for the small renal mass: 15-year experience at a single center.
    Zargar H; Samarasekera D; Khalifeh A; Remer EM; O'Malley C; Akca O; Autorino R; Kaouk JH
    Urology; 2015 Apr; 85(4):850-5. PubMed ID: 25704992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
    Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
    Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of cryoablation versus microwave ablation for small renal masses: is there a difference in outcome?
    Martin J; Athreya S
    Diagn Interv Radiol; 2013; 19(6):501-7. PubMed ID: 24084196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation.
    Bang HJ; Littrup PJ; Goodrich DJ; Currier BP; Aoun HD; Heilbrun LK; Vaishampayan U; Adam B; Goodman AC
    J Vasc Interv Radiol; 2012 Jun; 23(6):770-7. PubMed ID: 22538119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study.
    Hasegawa T; Yamanaka T; Gobara H; Miyazaki M; Takaki H; Sato Y; Inaba Y; Yamakado K
    Jpn J Radiol; 2018 Sep; 36(9):551-558. PubMed ID: 29968201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ablation versus Resection for Stage 1A Renal Cell Carcinoma: National Variation in Clinical Management and Selected Outcomes.
    Uhlig J; Kokabi N; Xing M; Kim HS
    Radiology; 2018 Sep; 288(3):889-897. PubMed ID: 29969077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ablation Therapy for Advanced Stage Non-Small Cell Lung Cancer: A National Cancer Database Study.
    Halsey K; Wu J; Su C; Hsieh B; Yi T; Collins SA; Kimia B; Zhang PJ; Healey T; Zhang Z; Bai HX
    J Vasc Interv Radiol; 2020 Aug; 31(8):1210-1215.e4. PubMed ID: 32460964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study.
    Nielsen TK; Lagerveld BW; Keeley F; Lughezzani G; Sriprasad S; Barber NJ; Hansen LU; Buffi NM; Guazzoni G; van der Zee JA; Ismail M; Farrag K; Emara AM; Lund L; Østraat Ø; Borre M
    BJU Int; 2017 Mar; 119(3):390-395. PubMed ID: 27488479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A National Cancer Database Analysis of Radiofrequency Ablation versus Stereotactic Body Radiotherapy in Early-Stage Non-Small Cell Lung Cancer.
    Lam A; Yoshida EJ; Bui K; Fernando D; Nelson K; Abi-Jaoudeh N
    J Vasc Interv Radiol; 2018 Sep; 29(9):1211-1217.e1. PubMed ID: 30061058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.